期刊文献+

可溶性CD44v6、VEGF检测在结核性腹水和卵巢癌性腹水鉴别诊断中的价值 被引量:3

Clinical values of detecting soluble CD44v6 and VEGF in differentiate tuberculous ascites and ascites in ovarian can cer
下载PDF
导出
摘要 目的探讨可溶性CD44变异性外量子(sCD44v6)及血管内皮生长因子(VEGF)对结核性、卵巢癌性腹水的诊断价值。方法选取39例卵巢癌性腹水、48例结核性腹水采用酶联免疫吸附试验(ELISA)检测腹水中sCD44v6及VEGF的水平,并进行相关性分析。结果卵巢癌性腹水组sCD44v6水平为(102±31)ng/ml,明显高于结核性腹水组(44±15)ng/ml,差异有统计学意义(P<0.01)。卵巢癌性腹水组VEGF水平为(684±210)ng/ml,明显高于结核性腹水组(90±11)ng/ml,差异有统计学意义(P<0.01)。sCD44v6以>60.5 ng/ml为阳性界值,sCD44v6诊断卵巢癌性腹水的敏感性为82.1%(32/39),特异性为87.5%(42/48);VEGF以>101.3 ng/ml为阳性界值,VEGF诊断卵巢癌性腹水的敏感性为92.3%(36/39),特异性为89.9%(43/48)。结论癌性腹水中的CD44v6、VEGF水平明显升高,sCD44v6、VEGF的检测对于结核性、卵巢癌性腹水的鉴别诊断有重要价值。 Objective To investigate the diagnostic value of soluble CD44v6(sCD44v6) and VEGF in the tuberculous ascites and ovarian cancer ascites.Methods Used enzyme linked immunosorbent assay(ELISA) to detect sCD44v6 and VEGF levels in 39 cases of ovarian cancer ascites,and 48 cases of tuberculous ascites.Results sCD44v6 was(102±31 ) ng/ml in ovarian cancer ascites group,which was significantly higher than tuberculous ascites(44±15) ng/ml(P〈0.01 ). VEGF was(684±210) ng/ml in ovarian cancer ascites,which was significant different from tuberculous ascites(90±11) ng/ ml(P〈0.01).sCD44v6〉60.5 ng/ml was defined as positive critical values,diagnosis of ovarian cancer ascites by sCD44v6 were as followed,sensitivity was 82.1%(32/39),specificity was 87.5%(42/48);VEGF〉101.3 ng/ml were defined as positive critical values,diagnosis of ovarian ascites by VEGF were as followed,sensitivity was 92.3%(36/39), specificity was 89.9%(43/48).Conclusion CD44v6 and VEGF in malignant ascites were significantly increased,detection of sCD44v6 and VEGF were of great value in differentiate ascites of tuberculosis and ovarian cancer.
出处 《疑难病杂志》 CAS 2011年第4期275-277,共3页 Chinese Journal of Difficult and Complicated Cases
基金 河北省卫生厅指令性项目(No.20100014)
关键词 腹水 CD44v6 可溶性 血管内皮生长因子 Ascites CD44v6 soluble Vascular endothelial growth factor
  • 相关文献

参考文献13

二级参考文献42

  • 1张玉华,陈萍,朴颖实,韩影,李弘,张伟东,刘宪军,巩雷,谢江.膀胱移行细胞癌中bax、bcl-2、CD44v6、nm23表达[J].临床与实验病理学杂志,2004,20(3):320-323. 被引量:1
  • 2马晓欣,苗青,王晓莉,张淑兰,曲桂红.C-erbB-2蛋白在子宫内膜病变中的表达及临床意义[J].中国现代医学杂志,2006,16(4):550-552. 被引量:2
  • 3陈晓玲,杨戎,贾咏存,魏莎莉.PTEN基因在早孕小鼠子宫内膜的表达规律[J].生殖与避孕,2007,27(2):89-93. 被引量:10
  • 4Mirecka J, Marx D, Schauer A, lmmunohistochemical localization of CD44 variants 5 and 6 in human gastric mucosa and gastric cancer. Anticancer Res, 1995, 15:1459-1465.
  • 5Hong RL, Lee WJ, Shun CT, et al. Expression of CD44 and its clinical implication in diffuse-type and intestinal-type gastric adenocarcinomas. Oncology, 1995, 52:334-339.
  • 6Ishida T. Immunohistochemical expression of the CD44 variant 6 in colorectal adenocarcinoma. Surg Today, 2000, 30:28-32.
  • 7Kawano T, Yanoma S, Nakamura Y, et al. Evaluation of soluble adhesion molecules CD44 ( CD44st, CD44v5, CD44v6 ), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer. Am J Otolaryngol, 2005, 26:308-313.
  • 8Yamane N, Tsujitani S, Makino M, et al. Soluble CD44 variant 6 as a prognostic indicator in patients with colorectal cancer. Oncology, 1999, 56:232-238.
  • 9Guo Y J, Liu G, Wang X, et al. Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer, Cancer Res, 1994, 54:422-426.
  • 10Nguyen VN, Mirejovsky, T, Melinova L, et al. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UPl and prognostic significance. Neoplasma, 2000, 47:400-408.

共引文献18

同被引文献30

  • 1Hua-chuanZheng,Meng-chunWang,Jin-yiLi,Xue-feiYang,Jin-minSun,YanXin.EXPRESSION OF MASPIN AND KAI1 AND THEIR CLINICOPATHOLOGICAL SIGNIFICANCE IN CARCINOGENESIS AND PROGRESSION OF GASTRIC CANCER[J].Chinese Medical Sciences Journal,2004,19(3):193-198. 被引量:30
  • 2邓玮,易永芬,刘丹丹.胃癌组织Maspin,uPA,MMP-7表达的意义[J].世界华人消化杂志,2006,14(7):660-665. 被引量:17
  • 3叶定伟,李长岭.前列腺癌发病趋势的回顾和展望[J].中国癌症杂志,2007,17(3):177-180. 被引量:118
  • 4冯晓莉,何群,陆敏,等译.泌尿系统及男性生殖器官肿瘤病理学及遗传学[M].北京:人民卫生出版社,2006:176.
  • 5Takahashi Y,Kitadai Y,Bucana C D,et al.Expression of vascular endothelial growth factor and its receptor,KDR,correlates with vascularity,metastasis,and proliferation of human colon cancer[J].Cancer Res,1995,55(18):3964-3698.
  • 6Liang Y,Brekken R A,Hyder S M.Vascular endothelial growth factor induces proliferation of breast cancer cells and inhibits the anti-proliferative activity of anti-hormones[J].Endocr Relat Cancer,2006,13(3):905-919.
  • 7Mizukami Y,Li J,Zhang X,et al.Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer[J].Cancer Res,2004,64(5):1765-1772.
  • 8Bos R,van der Groep P,Greijer A E,et al.Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma[J].Cancer,2003,97(6):1573-1581.
  • 9Buchler P,Reber H A,Buchler M,et al.Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer[J].Pancreas,2003,26(1):56-64.
  • 10Zhong H,De Marzo A M,Laughner E,et al.Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases[J].Cancer Res,1999,59(22):5830-5835.

引证文献3

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部